Tongda shares: Huashengbaili plans to reduce its shareholding by no more than 3%. Datong shares announced that Huashengbaili, a shareholder holding more than 5%, plans to reduce its shareholding by centralized bidding and block trading within three months after 15 trading days from the disclosure date of this announcement, with a total shareholding of no more than 2.664 million shares, accounting for 3% of the company's total share capital.On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)Publicity Department of the Communist Party of China Publishing Bureau: The leading plan of online publishing technology innovation is being formulated to promote the game industry to play a greater role in service technology innovation. Yang Fang, deputy director of Publicity Department of the Communist Party of China Publishing Bureau, said at the 2024 China Game Industry Annual Conference that Publicity Department of the Communist Party of China Publishing Bureau is currently working with relevant ministries to jointly formulate the leading plan of online publishing technology innovation to promote the game industry to play a greater role in service technology innovation. In addition, Yang Fang introduced that next year, Publicity Department of the Communist Party of China Publishing Bureau will focus on the online game boutique publishing project, and guide game enterprises to create more classic works that are deeply rooted in people's hearts and have been passed down for a long time.
Consumer stocks of Hong Kong stocks fell, with Budweiser Asia Pacific (01876.HK) and China Resources Beer (00291.HK) falling more than 5%, Nongfu Spring (09633.HK) and Mengniu Dairy (02319.HK) falling 4%, and Li Ning (02331.HK) and Anta Sports (02020.HK) falling more than 3%.What is the significance of fiscal and monetary policy adjustment? Expert: The path of "more active and promising" fiscal policy has been clarified. The Central Economic Work Conference, which closed yesterday, pointed out that a more active fiscal policy and a moderately loose monetary policy should be implemented next year. What kind of signals are released behind these policies? In terms of fiscal policy, the Central Economic Work Conference requested that a more active fiscal policy should be implemented next year, so as to improve the fiscal deficit ratio, increase the issuance of ultra-long-term special government bonds, increase the issuance of special bonds for local governments, optimize the structure of fiscal expenditure, and secure the bottom line of "three guarantees" at the grassroots level. Experts said that these requirements clarified the path of "more active and promising" fiscal policy. Focusing on vigorously boosting consumption, the Central Economic Work Conference requires that special actions to boost consumption should be implemented next year, the basic pension for retirees should be appropriately raised, and the "two new" policies (large-scale equipment renewal and trade-in of consumer goods) should be implemented. (CCTV News)Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.
Jinshanyun's information technology company increased its capital to USD 500 million. Tianyancha App shows that Jinshan Yun (Hainan Yangpu) Information Technology Co., Ltd. has undergone industrial and commercial changes recently, and its registered capital has increased from USD 400 million to USD 500 million. The company was established in August 2022, and its legal representative is Zou Tao. Its business scope is Internet domain name registration service, computer software and hardware and auxiliary equipment wholesale, technical service, technical development, technical consultation, technical exchange, technology transfer, technology promotion, information system integration service, software development and software sales, and it is wholly owned by Jinshanyun Co., Ltd.The Emergency Management Department made unannounced visits to inspect enterprises involved in dust explosion. Recently, the Emergency Management Department sent a working group to carry out unannounced visits to enterprises in key industries of industry and trade in Henan and Guangxi without greeting, accompanying reception and preparing materials, so as to promote the key areas of industry and trade to do a good job in the investigation and rectification of potential safety hazards in industry and trade this winter and next spring. It was found that some enterprises involved in dust explosion did not take explosion prevention and control measures, did not set up gas lock and ash unloading devices, did not set up spark detection and elimination devices, and did not implement dust cleaning system.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.
Strategy guide
Strategy guide
12-13